Is there clinical evidence that NanoFlashing reduces COVID-19 infections in hospitals?
Last reviewed: .
Is there clinical evidence that NanoFlashing reduces COVID-19 infections in hospitals?
The company publishes no clinical study of COVID-19 or of any other infection.
The peer-reviewed paper is Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23. The paper reports laboratory results on SARS-CoV-2 in contact with treated textile, on aerosolised bovine coronavirus passed through a test filter in a wind tunnel, and on bacterial viability on treated textiles; each result belongs to the article that was tested. Its authors state: “Our findings have several limitations, including a need for clinical studies on nosocomial infections in hospital or healthcare settings.” The Terms of Use state: “A laboratory reduction in a virus, bacterium, fungus, particle, or other endpoint does not establish a clinical benefit, fewer infections, disease prevention or treatment, or improved health.”
Source: Gong, Or, Sze et al., Microbiology Spectrum 12(9), e0409723, American Society for Microbiology, September 2024, doi 10.1128/spectrum.04097-23; C-POLAR — Terms of Use, section 3, https://cpolar.tech/terms/.
Reviewed on .
All questions